Cargando…

Pretreatment HIV drug resistance spread within transmission clusters in Mexico City

BACKGROUND: Pretreatment HIV drug resistance (HIVDR) to NNRTIs has consistently increased in Mexico City during the last decade. OBJECTIVES: To infer the HIV genetic transmission network in Mexico City to describe the dynamics of the local HIV epidemic and spread of HIVDR. PATIENTS AND METHODS: HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Matías-Florentino, Margarita, Chaillon, Antoine, Ávila-Ríos, Santiago, Mehta, Sanjay R, Paz-Juárez, Héctor E, Becerril-Rodríguez, Manuel A, del Arenal-Sánchez, Silvia J, Piñeirúa-Menéndez, Alicia, Ruiz, Verónica, Iracheta-Hernández, Patricia, Macías-González, Israel, Tena-Sánchez, Jehovani, Badial-Hernández, Florentino, González-Rodríguez, Andrea, Reyes-Terán, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021100/
https://www.ncbi.nlm.nih.gov/pubmed/31819984
http://dx.doi.org/10.1093/jac/dkz502
_version_ 1783497855250464768
author Matías-Florentino, Margarita
Chaillon, Antoine
Ávila-Ríos, Santiago
Mehta, Sanjay R
Paz-Juárez, Héctor E
Becerril-Rodríguez, Manuel A
del Arenal-Sánchez, Silvia J
Piñeirúa-Menéndez, Alicia
Ruiz, Verónica
Iracheta-Hernández, Patricia
Macías-González, Israel
Tena-Sánchez, Jehovani
Badial-Hernández, Florentino
González-Rodríguez, Andrea
Reyes-Terán, Gustavo
author_facet Matías-Florentino, Margarita
Chaillon, Antoine
Ávila-Ríos, Santiago
Mehta, Sanjay R
Paz-Juárez, Héctor E
Becerril-Rodríguez, Manuel A
del Arenal-Sánchez, Silvia J
Piñeirúa-Menéndez, Alicia
Ruiz, Verónica
Iracheta-Hernández, Patricia
Macías-González, Israel
Tena-Sánchez, Jehovani
Badial-Hernández, Florentino
González-Rodríguez, Andrea
Reyes-Terán, Gustavo
author_sort Matías-Florentino, Margarita
collection PubMed
description BACKGROUND: Pretreatment HIV drug resistance (HIVDR) to NNRTIs has consistently increased in Mexico City during the last decade. OBJECTIVES: To infer the HIV genetic transmission network in Mexico City to describe the dynamics of the local HIV epidemic and spread of HIVDR. PATIENTS AND METHODS: HIV pol sequences were obtained by next-generation sequencing from 2447 individuals before initiation of ART at the largest HIV clinic in Mexico City (April 2016 to June 2018). Pretreatment HIVDR was estimated using the Stanford algorithm at a Sanger-like threshold (≥20%). Genetic networks were inferred with HIV-TRACE, establishing putative transmission links with genetic distances <1.5%. We examined demographic associations among linked individuals with shared drug resistance mutations (DRMs) using a ≥ 2% threshold to include low-frequency variants. RESULTS: Pretreatment HIVDR reached 14.8% (95% CI 13.4%–16.2%) in the cohort overall and 9.6% (8.5%–10.8%) to NNRTIs. Putative links with at least one other sequence were found for 963/2447 (39%) sequences, forming 326 clusters (2–20 individuals). The inferred network was assortative by age and municipality (P < 0.001). Clustering individuals were younger [adjusted OR (aOR) per year = 0.96, 95% CI 0.95–0.97, P < 0.001] and less likely to include women (aOR = 0.46, 95% CI 0.28–0.75, P = 0.002). Among clustering individuals, 175/963 (18%) shared DRMs (involving 66 clusters), of which 66/175 (38%) shared K103N/S (24 clusters). Eight municipalities (out of 75) harboured 65% of persons sharing DRMs. Among all persons sharing DRMs, those sharing K103N were younger (aOR = 0.93, 95% CI 0.88–0.98, P = 0.003). CONCLUSIONS: Our analyses suggest age- and geographically associated transmission of DRMs within the HIV genetic network in Mexico City, warranting continuous monitoring and focused interventions.
format Online
Article
Text
id pubmed-7021100
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-70211002020-02-20 Pretreatment HIV drug resistance spread within transmission clusters in Mexico City Matías-Florentino, Margarita Chaillon, Antoine Ávila-Ríos, Santiago Mehta, Sanjay R Paz-Juárez, Héctor E Becerril-Rodríguez, Manuel A del Arenal-Sánchez, Silvia J Piñeirúa-Menéndez, Alicia Ruiz, Verónica Iracheta-Hernández, Patricia Macías-González, Israel Tena-Sánchez, Jehovani Badial-Hernández, Florentino González-Rodríguez, Andrea Reyes-Terán, Gustavo J Antimicrob Chemother Original Research BACKGROUND: Pretreatment HIV drug resistance (HIVDR) to NNRTIs has consistently increased in Mexico City during the last decade. OBJECTIVES: To infer the HIV genetic transmission network in Mexico City to describe the dynamics of the local HIV epidemic and spread of HIVDR. PATIENTS AND METHODS: HIV pol sequences were obtained by next-generation sequencing from 2447 individuals before initiation of ART at the largest HIV clinic in Mexico City (April 2016 to June 2018). Pretreatment HIVDR was estimated using the Stanford algorithm at a Sanger-like threshold (≥20%). Genetic networks were inferred with HIV-TRACE, establishing putative transmission links with genetic distances <1.5%. We examined demographic associations among linked individuals with shared drug resistance mutations (DRMs) using a ≥ 2% threshold to include low-frequency variants. RESULTS: Pretreatment HIVDR reached 14.8% (95% CI 13.4%–16.2%) in the cohort overall and 9.6% (8.5%–10.8%) to NNRTIs. Putative links with at least one other sequence were found for 963/2447 (39%) sequences, forming 326 clusters (2–20 individuals). The inferred network was assortative by age and municipality (P < 0.001). Clustering individuals were younger [adjusted OR (aOR) per year = 0.96, 95% CI 0.95–0.97, P < 0.001] and less likely to include women (aOR = 0.46, 95% CI 0.28–0.75, P = 0.002). Among clustering individuals, 175/963 (18%) shared DRMs (involving 66 clusters), of which 66/175 (38%) shared K103N/S (24 clusters). Eight municipalities (out of 75) harboured 65% of persons sharing DRMs. Among all persons sharing DRMs, those sharing K103N were younger (aOR = 0.93, 95% CI 0.88–0.98, P = 0.003). CONCLUSIONS: Our analyses suggest age- and geographically associated transmission of DRMs within the HIV genetic network in Mexico City, warranting continuous monitoring and focused interventions. Oxford University Press 2020-03 2019-12-09 /pmc/articles/PMC7021100/ /pubmed/31819984 http://dx.doi.org/10.1093/jac/dkz502 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Research
Matías-Florentino, Margarita
Chaillon, Antoine
Ávila-Ríos, Santiago
Mehta, Sanjay R
Paz-Juárez, Héctor E
Becerril-Rodríguez, Manuel A
del Arenal-Sánchez, Silvia J
Piñeirúa-Menéndez, Alicia
Ruiz, Verónica
Iracheta-Hernández, Patricia
Macías-González, Israel
Tena-Sánchez, Jehovani
Badial-Hernández, Florentino
González-Rodríguez, Andrea
Reyes-Terán, Gustavo
Pretreatment HIV drug resistance spread within transmission clusters in Mexico City
title Pretreatment HIV drug resistance spread within transmission clusters in Mexico City
title_full Pretreatment HIV drug resistance spread within transmission clusters in Mexico City
title_fullStr Pretreatment HIV drug resistance spread within transmission clusters in Mexico City
title_full_unstemmed Pretreatment HIV drug resistance spread within transmission clusters in Mexico City
title_short Pretreatment HIV drug resistance spread within transmission clusters in Mexico City
title_sort pretreatment hiv drug resistance spread within transmission clusters in mexico city
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021100/
https://www.ncbi.nlm.nih.gov/pubmed/31819984
http://dx.doi.org/10.1093/jac/dkz502
work_keys_str_mv AT matiasflorentinomargarita pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT chaillonantoine pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT avilariossantiago pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT mehtasanjayr pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT pazjuarezhectore pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT becerrilrodriguezmanuela pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT delarenalsanchezsilviaj pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT pineiruamenendezalicia pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT ruizveronica pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT irachetahernandezpatricia pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT maciasgonzalezisrael pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT tenasanchezjehovani pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT badialhernandezflorentino pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT gonzalezrodriguezandrea pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity
AT reyesterangustavo pretreatmenthivdrugresistancespreadwithintransmissionclustersinmexicocity